AP Syllabus focus:
‘Populations evolve resistance to antibiotics, pesticides, herbicides, and chemotherapy drugs under strong selective pressures.’
Resistance evolves when a chemical kills susceptible individuals but allows rare variants to survive and reproduce. Over generations, these survivors become common, reducing drug or chemical effectiveness in medicine, agriculture, and public health.
What “resistance” means in an evolutionary context
Resistance is an inherited ability of an organism or cell to survive and reproduce despite exposure to a drug (e.g., antibiotics, chemotherapy) or chemical (e.g., pesticides, herbicides). It is a population-level evolutionary change, not an individual “getting used to” a chemical.
Chemicals create strong selective pressures because they often cause large differences in survival and reproduction between phenotypes.
Selective pressure: an environmental factor that causes individuals with certain heritable traits to leave more offspring than others, changing trait (and allele) frequencies over time.
Core mechanism: selection on heritable variation
Key requirements for resistance evolution
Variation exists: within a population, some individuals are more tolerant than others.
Variation is heritable: differences are caused by genetic changes that can be passed on.
Differential reproductive success: resistant individuals contribute disproportionately to the next generation after exposure.
Why resistance evolves rapidly in many systems
Large population sizes increase the chance that resistant variants already exist.
Short generation times (especially microbes and pests) allow fast shifts in allele frequencies.
High-intensity selection (high mortality in susceptible types) produces strong, often directional selection toward resistance.
Resistance to antibiotics (bacteria)
How resistant bacteria arise
Resistance can be present before treatment begins or appear during population growth:
Spontaneous mutations can alter:
Drug targets (e.g., modified ribosomal proteins)
Membrane permeability (reduced drug entry)
Efflux pumps (increased drug export)
Enzymatic inactivation (drug-destroying enzymes)
Horizontal gene transfer (HGT) can spread resistance genes between bacteria:
Conjugation via plasmids carrying resistance genes

This diagram shows bacterial conjugation, where a donor cell forms a pilus to connect to a recipient cell and transfers a plasmid DNA strand. Conjugation is evolutionarily important because plasmids can carry antibiotic-resistance genes and spread them rapidly through a bacterial population, even across different strains or species. Source
Transformation by uptake of free DNA
Transduction via bacteriophages
How antibiotic use creates strong selection
When antibiotics are present:
Susceptible bacteria die or fail to reproduce.
Resistant bacteria survive, reproduce, and can rapidly dominate the population.
After treatment, resistant bacteria may persist and spread to new hosts, especially in settings with high antibiotic exposure.

This infographic summarizes how antibiotic-resistant bacteria move among humans, animals, food, and environmental reservoirs, emphasizing transmission pathways rather than just within-host selection. It helps connect the evolutionary origin of resistance (selection) to the public-health outcome: resistant strains spreading through interconnected systems. Source
Practices that intensify selection for resistance
Unnecessary antibiotic use (e.g., viral infections)
Incorrect dosing (too low to eliminate partially resistant cells)
Incomplete courses that leave survivors to repopulate
Widespread use in agriculture that exposes many bacterial populations repeatedly
Resistance to antivirals (viruses)
Viruses can evolve resistance when antiviral drugs block replication but variants with altered viral proteins replicate despite treatment. Rapid evolution is promoted by:
High replication rates
High mutation rates in many viral genomes
Large within-host populations that provide many opportunities for resistant variants to be selected
Resistance to chemotherapy (cancer cells)
Chemotherapy resistance is an evolutionary process occurring within the body:
Tumors often contain genetic heterogeneity, meaning different cancer cell lineages carry different mutations.

This figure illustrates clonal evolution in tumors: sequential mutations generate multiple subclones, producing genetic heterogeneity within the same cancer. Therapy can then act as a selective filter, preferentially reducing sensitive lineages while allowing pre-existing resistant subclones to expand and drive relapse. Source
Chemotherapy acts as a selective agent:
Sensitive cancer cells die.
Resistant clones survive and expand, leading to relapse or reduced treatment efficacy.
Common resistance mechanisms include:
Altered drug targets
Increased DNA repair
Drug efflux (transporters removing drugs from cells)
Failure to undergo apoptosis despite damage
Resistance to herbicides (weeds) and pesticides (insects)
Herbicide resistance
Herbicides impose selection in plant populations exposed repeatedly to the same mode of action. Resistance may evolve through:
Target-site changes that reduce herbicide binding
Metabolic resistance that detoxifies the herbicide
Changes in uptake, transport, or sequestration of the chemical
Pesticide (insecticide) resistance
Insect populations can evolve resistance via:
Target-site mutations in nervous system proteins
Increased detoxification enzymes
Behavioral avoidance (reduced contact with treated surfaces)
Because many pests have large population sizes and multiple generations per season, allele frequencies can shift quickly when selection is strong and consistent.
What slows (but rarely stops) resistance evolution
Reducing the strength and consistency of selection can delay resistance:
Combination therapy (multiple drugs with different targets) reduces the probability that a single genotype is resistant to all agents.
High adherence and appropriate dosing reduce survival of partially resistant variants.
In agriculture, strategies such as maintaining refuges (areas without pesticide/herbicide exposure) can preserve susceptible individuals, reducing the relative advantage of resistant genotypes.
Targeted, limited application decreases the number of selection events and the size of exposed populations.
FAQ
Some drug concentrations suppress susceptible cells but allow partially resistant variants to survive.
Keeping concentrations above that window (when clinically safe) reduces the opportunity for resistant subpopulations to expand.
A fitness cost may exist without the drug, but during treatment the survival advantage can outweigh the cost.
If drug exposure is frequent (e.g., hospitals, intensive farming), selection repeatedly favours resistance despite costs.
Cross-resistance: one mechanism protects against several related chemicals (e.g., a shared target or detox pathway).
Multi-drug resistance: resistance to multiple drugs, often via multiple mechanisms or broad efflux systems.
Biofilms can reduce drug penetration and create slow-growing cells that are less affected by many drugs.
This can allow survival during treatment, increasing the chance that true resistant mutants later arise and spread.
Mixtures can make survival require multiple resistance traits at once, lowering the probability of successful resistant genotypes.
Rotations help when resistance has costs or when different modes of action reduce consistent selection in one direction.
Practice Questions
Explain why antibiotic treatment can increase the frequency of resistance alleles in a bacterial population. (3 marks)
States that resistance is heritable/genetic (alleles/genes) and some bacteria already possess it (1)
Explains that antibiotics kill/inhibit susceptible bacteria, creating selection (1)
Explains that resistant bacteria survive and reproduce more, increasing the frequency of resistance alleles over generations (1)
A population of insects is exposed to a pesticide each generation. After several generations, mortality from the pesticide declines. Describe the evolutionary process that could explain this change and give two distinct genetic or physiological mechanisms that might underlie resistance. (6 marks)
Identifies the pesticide as a selective pressure causing differential survival (1)
Explains that there is pre-existing heritable variation in susceptibility within the insect population (1)
Describes that susceptible insects die leaving resistant insects to reproduce (natural selection) (1)
States that the frequency of resistance alleles/phenotypes increases over generations (1)
Mechanism 1 (any valid): target-site mutation reducing pesticide binding / altered receptor/ion channel etc. (1)
Mechanism 2 (any valid, distinct): increased detoxification enzymes / increased efflux transporters / reduced cuticle penetration etc. (1)
